Cholera
📧 Sign up to get email alerts when something new happens for Cholera.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-10EMA Authorised: Vaxchora (vibrio cholerae, strain cvd 103-hgr, live) — Bavarian Nordic A/S
Vaxchora (live Vibrio cholerae, strain CVD 103-HgR) has been authorised by the EMA for use in cholera.
-
EMA approval · 2025-09-24EMA Authorised: Vaxchora (vibrio cholerae, strain cvd 103-hgr, live) — Bavarian Nordic A/S
The European Medicines Agency authorised Vaxchora, a live attenuated oral vaccine against cholera, manufactured by Bavarian Nordic A/S. The …
-
EMA approval · 2022-04-06EMA Authorised: Dukoral (recombinant cholera toxin B subunit;vibrio cholerae 01) — Valneva Sweden AB
EMA authorised Dukoral, a cholera vaccine based on recombinant cholera toxin B subunit, for immunization against cholera.